drugset / Trial / NCT02224846

A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction

NCT02224846

Phase 4 Completed 635 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of the study drug, taken once daily, known as tadalafil in Chinese participants with erectile dysfunction (ED). The study will last about up to 25 months for each participant.

Timeline

Start
2014-10
Primary completion
2016-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 2.5 mg Oral
Subject Tadalafil Small molecule 5 mg Oral

Indications